The key finding of this study is that ATOH1-gene therapy results in an increase in the number of HCs, defined as myosinVIIa-positive cells with non-pyknotic nuclei residing within the OC, after profound aminoglycoside-induced SNHL in the mature GP. The gene discussed is ATOH1; the disease is sensorineural hearing loss disorder.